We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

1 hedge funds and large institutions have $204K invested in BioSpecifics Technologies Corp. in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 112

99% less funds holding

Funds holding: 113 → 1 (-112)

100% less capital invested

Capital invested by funds: $254M → $204K (-$254M)

Holders
1
Holders Change
-112
Holders Change %
-99.12%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
112
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$184K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$29.9M
2
BlackRock
BlackRock
New York
-$23.8M
3
RHJA
Rice Hall James & Associates
California
-$19.5M
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$17.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
1
UBS AM
Illinois
$204K +$184K +2,300 New
Renaissance Technologies
2
Renaissance Technologies
New York
– -$29.9M -565,356 Closed
BlackRock
3
BlackRock
New York
– -$23.8M -449,857 Closed
RHJA
4
Rice Hall James & Associates
California
– -$19.5M -369,359 Closed
Russell Investments Group
5
Russell Investments Group
United Kingdom
– -$17.5M -330,680 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$16.5M -311,761 Closed
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
– -$16M -303,785 Closed
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
– -$15.9M -301,321 Closed
Wells Fargo
9
Wells Fargo
California
– -$7.32M -138,508 Closed
State Street
10
State Street
Massachusetts
– -$7.3M -138,111 Closed
RA
11
Royce & Associates
New York
– -$6.98M -132,058 Closed
TSW
12
Thompson Siegel & Walmsley
Virginia
– -$5.46M -103,272 Closed
Prudential Financial
13
Prudential Financial
New Jersey
– -$5.43M -102,708 Closed
Geode Capital Management
14
Geode Capital Management
Massachusetts
– -$5.21M -98,647 Closed
Northern Trust
15
Northern Trust
Illinois
– -$5.09M -96,310 Closed
LSV Asset Management
16
LSV Asset Management
Illinois
– -$4.85M -91,808 Closed
PAIM
17
Punch & Associates Investment Management
Minnesota
– -$4.07M -77,101 Closed
AQR Capital Management
18
AQR Capital Management
Connecticut
– -$3.97M -75,230 Closed
Bank of New York Mellon
19
Bank of New York Mellon
New York
– -$3.17M -60,062 Closed
AL
20
AJO LP
Pennsylvania
– -$2.95M -55,793 Closed
KCM
21
Kennedy Capital Management
Missouri
– -$2.83M -53,481 Closed
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
– -$2.82M -49,480 Closed
WG
23
Winton Group
United Kingdom
– -$2.32M -43,990 Closed
First Manhattan
24
First Manhattan
New York
– -$2.04M -38,575 Closed
Man Group
25
Man Group
United Kingdom
– -$1.98M -37,391 Closed
1
2 3 4 5

BSTC Hedge Fund Activity: Q4 2020 in Review

1 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2020, worth a combined $204K — down 100% from $254M a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of BSTC and 1 opened new positions — a net loss of 111 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was UBS AM, opening a new position worth an estimated $184K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $29.9M sold.

  • 1 institutional investor held BioSpecifics Technologies Corp. (BSTC) as of Q4 2020, down from 113 in Q3 2020.
  • Funds reported $204K of BioSpecifics Technologies Corp. stock for Q4 2020, down 100% quarter-over-quarter.
  • 1 fund opened new BioSpecifics Technologies Corp. positions in Q4 2020 and 112 closed out, a net change of -111 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2020 was UBS AM, an estimated $184K added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2020 was Renaissance Technologies, an estimated $29.9M sold.

Based on aggregated 13F filings for Q4 2020.